These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 38913557)
1. Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma With Synchronous and Metachronous Nodal Disease. Eismann L; Zucker M; Dawidek MT; Reese SW; Calderon LP; Aulitzky A; Stief CG; Coleman JA; Kotecha RR; Carlo M; Chen Y; Reznik E; Russo P; Hakimi AA Urol Pract; 2024 Sep; 11(5):860-870. PubMed ID: 38913557 [TBL] [Abstract][Full Text] [Related]
2. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007 [TBL] [Abstract][Full Text] [Related]
3. Synchronous Bilateral RCC Is Associated With Poor Recurrence-Free Survival Compared With Unilateral RCC: A Single-Center Study With Propensity Score Matching Analysis. Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS Clin Genitourin Cancer; 2019 Jun; 17(3):e570-e580. PubMed ID: 30922860 [TBL] [Abstract][Full Text] [Related]
6. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144 [TBL] [Abstract][Full Text] [Related]
7. Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomy. Kuusk T; Klatte T; Zondervan P; Lagerveld B; Graafland N; Hendricksen K; Capitanio U; Minervini A; Stewart GD; Ljungberg B; Horenblas S; Bex A World J Urol; 2021 Sep; 39(9):3377-3383. PubMed ID: 33634323 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma. Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571 [TBL] [Abstract][Full Text] [Related]
9. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342 [TBL] [Abstract][Full Text] [Related]
10. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data. Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031 [TBL] [Abstract][Full Text] [Related]
11. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection. Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965 [TBL] [Abstract][Full Text] [Related]
12. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma. Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726 [TBL] [Abstract][Full Text] [Related]
13. Bilateral renal masses: pathologic concordance and impact of temporal presentation. Arnoux V; Fiard G; Descotes JL; Rambeaud JI; Long JA Minerva Urol Nefrol; 2012 Dec; 64(4):287-93. PubMed ID: 23288216 [TBL] [Abstract][Full Text] [Related]
14. Analysis of lymph node dissection in patients with ≥7-cm renal tumors. Feuerstein MA; Kent M; Bazzi WM; Bernstein M; Russo P World J Urol; 2014 Dec; 32(6):1531-6. PubMed ID: 24402173 [TBL] [Abstract][Full Text] [Related]
15. Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis. Wei Y; Wang M; Jin Y; Zhou C; Lyu J World J Urol; 2020 Jun; 38(6):1579-1585. PubMed ID: 31065795 [TBL] [Abstract][Full Text] [Related]
16. Impact of Systemic Therapy in Metastatic Renal-Cell Carcinoma Patients With Synchronous and Metachronous Brain Metastases. Parmar A; Soliman H; Sahgal A; Bjarnason GA Clin Genitourin Cancer; 2020 Jun; 18(3):e224-e232. PubMed ID: 32139300 [TBL] [Abstract][Full Text] [Related]
17. Bilateral renal cancers: oncological and functional outcomes. Berczi C; Thomas B; Bacso Z; Flasko T Int Urol Nephrol; 2016 Oct; 48(10):1617-22. PubMed ID: 27379623 [TBL] [Abstract][Full Text] [Related]
18. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival. Takagi T; Kondo T; Izuka J; Kobayashi H; Tomita E; Hashimoto Y; Tanabe K Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022 [TBL] [Abstract][Full Text] [Related]
19. Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience. Bazzi WM; Sjoberg DD; Feuerstein MA; Maschino A; Verma S; Bernstein M; O'Brien MF; Jang T; Lowrance W; Motzer RJ; Russo P J Urol; 2015 Jun; 193(6):1911-6. PubMed ID: 25524244 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of functional outcome of bilateral kidney tumors after sequential surgery. Kim JK; Kim H; Lee H; Oh JJ; Lee S; Hong SK; Kwak C; Byun SS BMC Cancer; 2021 May; 21(1):592. PubMed ID: 34024273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]